Hao Chen

发表

Discovery of new LXRβ agonists as glioblastoma inhibitors.

Zizhen Zhang, Qiong Gu, Jun Xu, 2020, European journal of medicinal chemistry.

Discovery of novel liver X receptor inverse agonists as lipogenesis inhibitors.

Zizhen Zhang, Qiong Gu, Jun Xu, 2020, European journal of medicinal chemistry.

Cembrane-type diterpenoids from Macaranga pustulata.

Qiong Gu, Jun Xu, Huihao Zhou, 2018, Fitoterapia.

Chemical constituents from Daphne tangutica and their cytotoxicity against nasopharyngeal carcinoma cells.

Qiong Gu, Jun Xu, Hao Chen, 2018, Fitoterapia.

Two new lignans from the aerial parts of Saururus chinensis with cytotoxicity toward nasopharyngeal carcinoma.

Qiong Gu, Jun Xu, Hao Chen, 2020, Fitoterapia.

Synthesis and evaluation of andrographolide derivatives as potent anti-osteoporosis agents in vitro and in vivo.

Qiong Gu, Jun Xu, Huihao Zhou, 2021, European journal of medicinal chemistry.

Discovery of tissue selective liver X receptor agonists for the treatment of atherosclerosis without causing hepatic lipogenesis.

Qiong Gu, Jun Xu, Huihao Zhou, 2019, European journal of medicinal chemistry.

Discovery of Spiro[pyrrolidine-3,3'-oxindole] LXRβ Agonists for the Treatment of Osteoporosis.

Dane Huang, Qiong Gu, Jun Xu, 2022, Journal of medicinal chemistry.

Identify liver X receptor β modulator building blocks by developing a fluorescence polarization-based competition assay.

Zizhen Zhang, Qiong Gu, Jun Xu, 2019, European journal of medicinal chemistry.

Structurally Selective Mechanism of Liver X Receptor Ligand: In Silico and In Vitro Studies

Zhihong Liu, Peng Ding, Xin Yan, 2019, J. Chem. Inf. Model..